Research Corporation Technologies

Particle Dynamics Announces Sale to New Ownership Group Led by BroadOak Capital Partners

Retrieved on: 
Wednesday, September 29, 2021

Particle Dynamics, a global leader in particle processing, delivery technologies, and finished dose manufacturing for pharmaceutical, over-the-counter (OTC), and nutraceutical companies, has sold from Edgewater Capital Partners to a new ownership group led by BroadOak Capital Partners (BroadOak).

Key Points: 
  • Particle Dynamics, a global leader in particle processing, delivery technologies, and finished dose manufacturing for pharmaceutical, over-the-counter (OTC), and nutraceutical companies, has sold from Edgewater Capital Partners to a new ownership group led by BroadOak Capital Partners (BroadOak).
  • The new ownership group comprises BroadOak, Research Corporation Technologies (RCT), and Farragut Capital Partners (Farragut); BroadOak and Farragut provided subordinated debt to Particle Dynamics in 2019 as part of a recapitalization.
  • Particle Dynamics combines deep particle processing and delivery technology expertise to provide the global healthcare industry functionally superior products and custom manufacturing services in US-based GMP, FDA inspected facilities.
  • The new group led by BroadOak Capital Partners is ideal to accelerate the growth of our company based on our vision to be a partner of choice recognized for our technologies and our people.